Effects of Topical Diclofenac on Tumor Metabolism
NCT01935531
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Actinic Keratoses
Interventions
DRUG:
3% diclofenac in 2.5% hyaluronic acid gel
Sponsor
University Hospital Regensburg
Collaborators
[object Object]